ARCHIVES

Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment

This article is from The Cancer Letter archive.

Vol. 22 No. 05 | February 2, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Wynder Group Finds No Association Between Coffee, Pancreatic Cancer

August 19, 1983

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

November 18, 1988

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981

Regulatory Agencies Get Data For Action Against One Of World’s Most Widely Used Carcinogens

October 6, 1978